article thumbnail

Team behind RECOVERY trial of COVID drugs casts its net wider

pharmaphorum

The UK scientists that ran one of the largest trials of experimental COVID-19 drugs have formed a non-profit company that will apply the methodology to other disease areas – with $6.8 ” Those trials also need to be large, involve a diverse range of individuals, and able to be run at reduced cost, said Landray. .

Trials 80
article thumbnail

Patient involvement in trial design: looking to the future

pharmaphorum

COVID-19 has transformed the way we think about patient participation in trial design – but there are still many barriers to overcome in improving engagement. Speakers at the NIHR’s recent virtual event for the pharma industry discussed best practices for bringing patient insights into research.

Trials 117
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Your HCP marketing just became harder, a lot harder

World of DTC Marketing

doctors surveyed in the same time period, 77% said their trust in the CDC has decreased and 48% said their trust in the FDA has decreased. According to Medscape, “doctors and nurses reported relatively lower trust in the CDC than WebMD readers. Out of nearly 450 U.S.

Marketing 187
article thumbnail

Communicating with HCPs via email

World of DTC Marketing

SUMMARY: Doctors said they were dissatisfied were marketing emails (46%), telephone sales calls with sales reps (42%), and both webinars and websites (each at 39%) from pharma companies, according to Indegene. Also, one message to ALL doctors sold not make sense. They especially like data about clinical trial updates.

Doctors 180
article thumbnail

Using technology to reassess the clinical trial landscape

pharmaphorum

Josh Sackman, president and co-founder of AppliedVR, and Web Sun, president and co-founder of Komodo Health, relay how their newly formed collaboration reshapes the clinical trial process by using data, helping to cut costs and allowing for evaluation of broader patient populations. . Distinct offerings.

article thumbnail

HCP’s use of social media: the good and the not so good

World of DTC Marketing

HCPs don’t necessarily want pharma trying to sell products via social media. The best approach is to use social media to connect HCPs to clincial information and drug trials. A leading pharma company recently sponsored a series of Q&A around the use of their new cancer drug.

Nurses 294
article thumbnail

Edelman Trust Barometer raises questions

World of DTC Marketing

But do doctors trust the system? consumers’ trust in pharma is low, despite the industry’s contributions to ending the pandemic: Only 15% of U.S. consumers say they trust pharma companies more than they did before the COVID-19 pandemic, according to Accenture’s 2021 survey.